Fig. 1 · Structure
Documents & Downloads
Semaglutide Main Chain (9-37)
Semaglutide Prodrug
Semaglutide Main Chain (9-37) serves as a peptide starting material for the synthesis of the semaglutide prodrug. This compound is integral in facilitating the development of semaglutide, which is a GLP-1 receptor agonist known for its role in enhancing glucose-dependent insulin secretion and reducing appetite. It is widely applicable in diabetes research and therapeutic development aimed at metabolic disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 1169630-82-3 |
| Applications | Semaglutide Prodrug |
| Formula | C142H216N38O45 |
| Molecular Weight | 3175.46 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.